M. Delcroix (Leuven, Belgium), H. Olschewski (Graz, Austria)
Results of a 12-week outpatient cardiovascular rehabilitation in patients with idiopathic pulmonary arterial hypertension (iPAH)
K. Boutet, G. Garcia, B. Degano, M. Gonzalves-Tavares, C. Tcherakian, X. Jaïs, M. Humbert, P. Escourrou, G. Simonneau, O. Sitbon (Clamart, France)
|   |
Non-invasive hemodynamic assessment in patients with pulmonary hypertension
S. Desole, C. Seemann, P. Heininger, R. Hiemetzberger, S. Mueller, C. M. Kaehler (Innsbruck, Austria)
| |
The REVEAL registry: a tool for the evaluation of PAH disease management
R. Barst, M. McGoon, R. Benza, D. Badesch, S. Giles, K. Feldkircher, D. Miller (New York, NY, Rochester, MN, Birmingham, AL, Denver, CO, South San Francisco, CA, San Francisco, CA, United States Of America)
| |
Clinical characteristics of pulmonary arterial hypertension in Ireland: results of a national register
D. O‘Callaghan, S. Doherty, S. Gaine (Dublin, Ireland)
| |
Incidence of pulmonary arterial hypertension related to systemic sclerosis: a 3-year nationwide longitudinal study
M. Humbert, P. de Groote, V. Gressin, J. Sibilia, E. Diot, P. Carpentier, L. Mouthon, P. Y. Hatron, P. Jego, Y. Allanore, K. P. Tiev, C. Agard, A. Cosnes, D. Cirstea, J. Constans, D. Farge, J. F. Viallard, J. R. Harle, P. Clerson, E. Hachulla (Clamart, Pa
| |
Ambrisentan therapy for patients with PAH associated with connective tissue disease (PAH-CTD): one year follow-up
N. Galie, D. Richards, T. Hutchinson, C. Dufton, On Behalf of the ARIES Study Group (Bologna, Italy; Harlow, Essex, United Kingdom; Westminster, CO, United States Of America)
| |
Pulmonary pressure at rest and during slight exercise might have prognostic relevance in patients at risk for pulmonary arterial hypertension
G. Kovacs, R. Maier, S. Scheidl, C. Hesse, E. Aberer, M. Brodmann, W. Salmhofer, W. Graninger, E. Gruenig, H. Olschewski (Graz, Austria; Heidelberg, Germany)
| |
NT-proBNP correlation with disease severity in PAH-SSc versus IPAH
S. Mathai, H. Champion, A. Zaiman, R. Girgis, P. Hassoun (Baltimore, MD, United States Of America)
| |
Cardiopulmonary exercise testing, six minute walk and hemodynamics in patients with chronic thromboembolic pulmonary hypertension (CTEPH)
J. Klemm, H. Wilkens, C. Frantz, T. Kramm, G. W. Sybrecht (Homburg, Merzig, Germany)
| |
Pulmonary artery distensibility correlates with functional response to sildenafil in distal chronic thrombo-embolic pulmonary hypertension
M. Toshner, J. Suntharalingam, E. Soon, N. Screaton, D. Gopalan, J. Pepke-Zaba (Cambridgeshire, Bath, United Kingdom)
| |
Prognostic factors in non-surgical chronic thromboembolic pulmonary hypertension
R. Condliffe, D. G. Kiely, J. S. R. Gibbs, P. A. Corris, A. J. Peacock, D. P. Jenkins, K. Goldsmith, J. G. Coghlan, J. Pepke-Zaba (Cambridge, Sheffield, London, Newcastle-upon-Tyne, Glasgow, United Kingdom)
| |
Haemodynamic correlation and prognostic value of ventricular mass index (VMI) in non-surgically treated chronic thromboembolic pulmonary hypertension (CTEPH)
R. Condliffe, N. Woodhouse, C. A. Elliot, J. Wild, D. Hagger, I. J. Armstrong, C. Davies, C. Hill, D. G. Kiely (Sheffield, United Kingdom)
| |
C-reactive protein and platelet-activating factor-acetylhydrolase activity: new predictors of outcome in pulmonary hypertension
R. Quarck, T. Nawrot, E. Ninio, B. Meyns, D. Van Raemdonck, E. Verbeken, M. Delcroix (Leuven, Belgium; Paris, France)
| |
Pleural effusions induced by right heart failure in patients with idiopathic and familial pulmonary arterial hypertension
K. J. Tang, I. M. Robbins, R. W. Light, C. M. Xie (Guangzhou/Guangdong, China; Nashville, TN, United States Of America)
| |
Assessment of satisfaction in patients with pulmonary hypertension treated with epoprostenol
E. Vandevelde, V. Vanloo, E. Smeyers, V. De Broyer, C. Vanaken, M. Delcroix (Leuven, Belgium; Battambang District, Cambodia)
| |
Endothelin and high altitude pulmonary hypertension
B. Kojonazarov, J. Isakova, M. Kochkorova, A. Maripov, T. Sooronbaev, M. Mirrakhimov, N. Morrell, M. Wilkins, A. Aldashev (Bishkek, Kyrgyzstan; Cambridge, London, United Kingdom)
| |
Pulmonary distension restrains pulmonary blood flow during exercise in COPD patients
L. Bertoletti, J. M. Vergnon, F. Costes (Saint-Etienne, France)
| |
Circulating endothelial progenitor cells in patients with Eisenmenger syndrome and idiopathic pulmonary arterial hypertension
S. van Eijl, G. P. Diller, D. O. Okonko, L. S. Howard, O. Ali, T. Thum, S. J. Wort, E. Bédard, J. S. R. Gibbs, J. Bauersachs, A. J. Hobbs, M. R. Wilkins, M. A. Gatzoulis, J. Wharton (London, United Kingdom; Würzburg, Germany)
| |
Pregnancy and pulmonary arteriovenous malformations
C. Shovlin, C. Mordin, J. Jackson, J. M. B. Hughes, M. Sheppard (London, United Kingdom)
| |
Transcatheter embolization of pulmonary arterio-venous malformations (PAVMs) – does a successful occlusion last for ever?
O. Almås, A. Naalsund, P. Giæver, G. Hafsahl, R. Andersen, E. Dorenberg (Oslo, Norway)
| |